LANDRICH GROUP
Our Mission
​
​
At Landrich Group, our mission is to provide ‘best in class’ Clinical, Quality and Regulatory consulting services to our medical devices, IVD and pharmaceutical clients. ​
​
The Landrich Group provides a broad range of customized solutions to fit our clients needs across every stage of their company’s development including design & development, analytical & clinical performance evaluations, manufacturing and post-market support.
Meet The Founder
Serving our clients clinical research needs for over 20 years
An experienced, self-motivated, quality-focused clinical project leader with over 20 years of clinical research management and monitoring experience. Working effectively to manage clinical activities for Pharmaceutical, Medical Device & In vitro Diagnostic Manufacturers. Experience in multiple therapeutic areas such as Ophthalmology, Dermatology, Hematology, Transfusion Medicine, Companion Diagnostics, Cardiology, Oncology, Infectious Disease, & Diabetes. Proven track record of well-managed clinical studies resulting in successful inspections and regulatory approvals.
​
Tina loves to read, take sewing classes with her friends, and in her spare time she volunteers her time and talents to her favorite charity and scientific organizations.
Tina Landess
Meet Our Team
Our Services
Biostatistics
Data Management
Clinical Services(CRO)
U.S. Agent
SOP Development
Regulatory Affairs
GCP/GMP Training
Our Industry Experience and programs supported
by Landrich Group
Extensive experience managing clinical studies and supporting clients across the globe
%20(3)_edit.png)
_edited.png)
_edited.png){kind=small}
Sponsor
Regions
Site
The Landrich Group has conducted trials in 6 / 7 continents as of 2025
News
Risk-Based Monitoring: Challenges and Opportunities
​
Since the COVID-19 pandemic, clinical trials have transitioned from traditional monitoring methods towards a more flexible approach known as Risk-Based Monitoring (RBM). RBM offers a potential paradigm shift in the speed, efficiency, and costs for bringing new therapeutic, medical device, and diagnostic products to market.
Microbio conducts commercial evaluation trials in Ecuador
​
Australian biotech scale-up Microbio has started commercial evaluation trials in Ecuador prior to launching its flagship InfectID-BSI (Bloodstream Infection) test in South America.
​